Introduction
The following table contains a summary of product launches and approvals identified in international markets in recent weeks.
| Generic name | Trade name (Company) | Indication/category | Country |
|---|---|---|---|
| Balsalazide (L) | Colazal (Salix Pharmaceuticals) | Treatment of ulcerative colitis | US |
| Caspofungin (A) | Cancidas (Merck & Co.) | Treatment of invasive aspergillosis | US |
| Crotalid antivenin (L) | CroFab (Protherics) | Treatment of snake bites | US |
| Linezolid (A) | Zyvox (Pharmacia Corporation) | Treatment of Gram-positive infections | UK |
| Pneumococcal conjugate vaccine (A) | Prevenar (Wyeth-Lederle Vaccines) | Prevention of invasive pneumococcal disease | EU |
| Ziprasidone (A) | NA (Pfizer) | Treatment of schizophrenia | US |
A = approved; L = launched; EU = European Union; NA = not available.
© 2001 Adis Data Information BV
Cite this: New in the Marketplace - Medscape - Mar 12, 2001.
